Liver, Bile Duct and Pancreas Tumor Program

Liver Tumor Publications

Wagman LD (Ed.) (2015) Hepatocellular Cancer, Cholangiocarcinoma, and Metastatic Tumors of the Liver. Surgical Oncology Clinics of North America. New York, NY: El Sevier

Wagman LD. Importance of response to neoadjuvant therapy in patients with liver-limited mCRC when the intent is resection and/or ablation. Clin Colorectal Cancer. 2013 Dec;12(4):223-32

Wagman LD. Hepatic Artery Infusion: Still an Option? Ann Surg Oncol. 2013 May 21.

McCahill LE, Wagman LD, et al. Primary mFOLFOX6 + bevacizumab without resection of the primary tumor for patients presenting with surgically unrespectable metastatic colon cancer and an intact asymptomatic colon cancer: Definitive analysis of NSABP Trial C-10. J Clin Oncol. 2012 Sep 10;30(26):3223-8. Epub 2012 Aug 6

Foster B, Wagman LD. Surgical Stress Induced Oxaliplatin Associated Interstitial Pneumonitis. Am Surg, Volume 77, Number 12, December 2011 , pp. 272-273(2) Epub at<>

Soriano PA, Liu N, Castillo E, Foster B, Artinyan A, Kim J, Huang W, Wagman LD. Oxaliplatin But Not Irinotecan Impairs Post-Hepatectomy Liver Regeneration In A Murine Model. Int J Hepatol. 2011;2011:490463. Epub 2011 Nov 22.

Holt A, Wagman LD, Senthil M, et al.: Transarterial Radioembolization with Yttrium-90 for Regional Management of Hepatocellular Cancer: The Early Results of a Nontransplant Center. Am Surg 2010 Oct;76(10):1079-83.

Meng Z, Wang Y, Wang L, Jin W, Liu N, Pan H, Liu L, Wagman LD, et al. FXR regulates liver repair after CCl4-induced toxic injury. Mol Endocrinol. 2010 May; 24(5):886-97. Epub 2010 Mar 8

Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, Wagman LD, Nissen N, Colquhoun SD, Kim J. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010 Mar1;116(5):1367-77.

Huang W, Wagman LD. FXR regulates liver repair after CCL4-induced toxic injury. Mol Endocrinol . 2010 May;24(5):886-97. Epub 2010 Mar 8.

Alberts SR, Roh MS, Mahoney MR, O'Connell MJ, Nagorney DM, Wagman LD, Smyrk TC, Weiland TL, Lai LL, Schwarz RE, Molina R, Dentchev T, Bolton JS. Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-6 J Clin Oncol. 2010 Feb 10;28(5):853-8. Epub 2010 Jan 4.

Wagman LD, Byun TE . Managing colorectal cancer liver metastases. Oncology 2009;23(12):1063-71.

Wagman LD, Lee B, Castillo E, El-Bayar H, Lai L. Liver Resection Using a Four-Prong Radiofrequency Transection Device. The American Surgeon Oct 2009;75(10):991-994..

Wagman LD, Kim J. Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization. J Surg Oncol. 2009 Sept 1:100(3):184-90.

Mailey, B, Truong, C, Artinyan, A, Khalili, J, Sanchez-Luege, N, Denitz, J, Marx, H, Wagman LD, Kim, J. Surgical Resection of Primary and Metastatic Hepatic Malignancies following Portal Vein Embolization. J Surg Oncol. 2009 Sep 1:100(3):184-90.

Yen Y, Lim DW, Chung V, Morgan RJ, Leong LA, Shibata SI, Wagman LD, et al. Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial. Am J Clin Oncol. 2008 Aug;31(4):317-22.

Artinyan A, Nelson R, Soriano P, Chung V, Retseck J, Reynolds J, Marx H, Kim J, Wagman LD. Treatment response to transcatheter arterial embolization and chemoembolization in primary and metastatic tumors of the liver. HPB 2008;10:396-404.

Chung HH, Razavi MK, Sze DY, Frisoli JK, Kee ST, Dake MD, Hellinger JC, Kang BC. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications? J Gastroenterol Hepatol 2008 Jan;23(1):95-101.

Sun V, Ferrell B, Juarez G, Wagman LD, Yen Y, Chung V. Symptom concerns and quality of life in hepatobiliary cancers. Oncology Nursing Forum 2008: Online. 35(3):E45-52.

Wagman LD. Expanded criteria for surgery for liver metastases: thoughtful science or diamond mining?[comment]. Journal of Clinical Oncology 2008: 26(22):3663-4.

Alberts, Steven R,Wagman LD. Chemotherapy for colorectal Cancer Liver Metastases. The Oncologist 2008: 1063-1073

Feliberti EC, Nelson RA, Wagman LD. Radiofrequency ablation of small hepatic malignancies provides local control equal to resection. AHPBA Meeting, April 2007.

Ha BY, Ahmed A, Sze DY, Razavi MK, Simpson N, Keeffe EB, Nguyen MH. Long-term survival of patients with unrespectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion. Aliment Pharmacol Ther 2007 Sep;15:26(6):839-46.

Wagman LD. More tools, new strategies: Enlarging the therapeutic scope for the patient with liver metastases from colorectal cancer. J Surg Onc 2007;95(1):1-3.

Feliberti E, Wagman LD. Radiofrequency ablation of liver metastases from colorectal carcinoma. Cancer Control.2006;13(1):48-51.

Roybal JJ, Feliberti EC, Rouse L, Wagman LD. Pump removal in infected patients with hepatic chemotherapy pumps: when is it necessary? Am Surg 2006;72(10):880-884.

Benson AB 3rd, Bekaii-Saab T, Ben-Josef E, Blumgart L, Clary BM, Wagman LD et al. Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Can Netw 2006;4(8):728-750.

Hsu CP, Razavi MK, So SK, Parachikov IH, Benaron DA. Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. J Vasc Interv Radiol 2005 Nov;16(11):1473-8.

Faynsod M, Wagman LD, Longmate J, Carroll M, Leong LA. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy. J Clin Oncol 2005;23(22):4876-4880.

Podnos YD, Wagman LD. Surgical management of hepatic breast cancer metastases. Oncology 2005;19(12):1583-7.

Razavi MK. Complications of RF Ablation: An invited commentary. Radiographics 2003 Jan-Feb;23(1):134-6

Kim P, Prapong W, Sze DY, So SK, Razavi MK. Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Tech Vasc Interv Radiol 2002 Sep;5(3):127-31

Sze D, Razavi MK, So SKS, Jeffrey RB. Impact of the use of multi-detector CT hepatic arteriography on the planning of chemoembolization treatment for hepatocellular carcinoma. AJR Am J Roentgenol 2001;177:1339-1345.

Wagman LD, Pigazzi A. Hepatic artery infusion: Robotic assisted pump placement. In: International Principles of Lap Surg (In Press)